Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ARWR | BMRN | ABVX | ||
| Company | Arrowhead Pharma | Biomarin Pharmaceuticals | Abivax Sa ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 76.50 | 54.15 | 124.84 | ||
| High | 77.92 | 54.55 | 126.74 | ||
| Low | 72.61 | 53.53 | 121.21 | ||
| Latest | 72.69 | 54.06 | 122.74 | ||
| Change | -5.26 | -0.06 | -1.91 | ||
| % Change | -6.75% | -0.11% | -1.53% | ||
| Volume | 2,700,200 | 1,972,400 | 917,500 | ||
| 20-Day Average Volume | 1,890,080 | 1,754,015 | 920,135 | ||
| Previous Close | 77.95 | 54.12 | 124.65 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 72.25 | 54.30 | 117.95 | ||
| 20-Day Raw Stochastic | 58.11% | 32.20% | 72.21% | ||
| 20-Day Relative Strength | 55.35 | 45.84 | 53.79 | ||
| Weighted Alpha | +301.55 | -8.73 | +139.71 | ||
| Today's Opinion | 88% Buy | 72% Sell | 64% Buy | ||
| Previous Opinion | 88% Buy | 72% Sell | 64% Buy | ||
| Last Month's Opinion | 72% Buy | 8% Sell | 48% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.83% since 05/01/26 | unch since 05/01/26 | +4.36% since 05/01/26 | ||
| Low | 72.61 on 05/08/26 | 52.65 on 05/05/26 | 114.85 on 05/04/26 | ||
| High | 79.48 on 05/06/26 | 57.44 on 05/05/26 | 129.18 on 05/06/26 | ||
| 1-Month | |||||
| %Chg | +12.94% since 04/08/26 | -5.49% since 04/08/26 | +3.18% since 04/08/26 | ||
| Low | 63.27 on 04/13/26 | 52.46 on 04/29/26 | 106.00 on 04/29/26 | ||
| High | 79.48 on 05/06/26 | 57.44 on 05/05/26 | 129.18 on 05/06/26 | ||
| 3-Month | |||||
| %Chg | +12.66% since 02/06/26 | -7.00% since 02/06/26 | +4.31% since 02/06/26 | ||
| Low | 54.02 on 03/13/26 | 52.46 on 04/29/26 | 100.15 on 03/30/26 | ||
| High | 79.48 on 05/06/26 | 66.28 on 02/24/26 | 133.42 on 02/20/26 | ||
| 6-Month | |||||
| %Chg | +85.29% since 11/07/25 | +5.05% since 11/07/25 | +16.60% since 11/07/25 | ||
| Low | 37.06 on 11/20/25 | 50.90 on 12/15/25 | 100.15 on 03/30/26 | ||
| High | 79.48 on 05/06/26 | 66.28 on 02/24/26 | 148.83 on 12/24/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 10,178,925 | 10,448,933 | 9,732,178 | ||
| Shares Outstanding, K | 140,032 | 193,284 | 79,291 | ||
| Annual Sales | 829,450,000 | 3,221,250,000 | 0 | ||
| Annual Net Income | -1,630,000 | 348,900,000 | -380,270,000 | ||
| Last Quarter Sales | 264,030,000 | 874,560,000 | 0 | ||
| Last Quarter Net Income | 30,810,000 | -46,570,000 | -90,870,000 | ||
| 60-Month Beta | 1.28 | 0.23 | 0.84 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.93 on 05/07/26 | 0.76 on 05/04/26 | -1.19 on 03/23/26 | ||
| Earnings Date | 08/06/26 | 08/03/26 | 06/01/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 26.66 | 0.00 | ||